Ligand · ERA

ERA · (7Z,15E,17E)-N-[(2S,3S,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tricosa-7,15,17-trienamide

ERA, (7Z,15E,17E)-N-[(2S,3S,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tricosa-7,15,17-trienamide (C41 H75 N O3, 630.0 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…

Component: ERA
Formula: C41 H75 N O3
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

ERA in 2 structures; the first of them:

3AU1 · Crystal structure of mouse CD1d in complex with ganglioside GD3 · ERA A315 · binds PHE10, CYS12, GLN14, SER28, VAL30, ILE47, TRP63, LEU66 and 23 more
3AU1 · Crystal structure of mouse CD1D in complex with ganglioside GD3 · ERA A315 · binds PHE10, CYS12, GLN14, SER28, VAL30, ILE47, TRP63, LEU66 and 23 more

Residues it binds most

LEU 2, PHE 2, VAL 2, ILE 2, ASP 2, SER 2, THR 2, TRP 2, ALA 2, CYS 2 (residue and the binding sites it lines).

Found with

BGC · beta-D-glucopyranose
BMA · beta-D-mannopyranose
FUC · alpha-L-fucopyranose
GAL · beta-D-galactopyranose
GLC · alpha-D-glucopyranose
MAN · alpha-D-mannopyranose
NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.